David A. Simon
@davidasimon.bsky.social
Associate Professor, Northeastern University School of Law
www.davidasimon.us
Co-Director, Amy J. Reed Collaborative for Medical Device Safety
https://www.safemedicaldevices.org/
Researcher, the CLASSICA Project
https://classicaproject.eu/team/
www.davidasimon.us
Co-Director, Amy J. Reed Collaborative for Medical Device Safety
https://www.safemedicaldevices.org/
Researcher, the CLASSICA Project
https://classicaproject.eu/team/
maybe, but depends on which drugs - for example, there is a cancer drug--that may qualify for mandatory off-label use reimbursement depending on compendia ratings.
November 13, 2025 at 7:51 PM
maybe, but depends on which drugs - for example, there is a cancer drug--that may qualify for mandatory off-label use reimbursement depending on compendia ratings.
Medical treatments can work, but they don't always --or even work the same for everyone. And sometimes taking a medication is only one aspect of the treatment. Med often runs out of solutions in the standard playbook. People then head elsewhere. They may not get better, but they will get something
November 13, 2025 at 2:35 PM
Medical treatments can work, but they don't always --or even work the same for everyone. And sometimes taking a medication is only one aspect of the treatment. Med often runs out of solutions in the standard playbook. People then head elsewhere. They may not get better, but they will get something
November 13, 2025 at 1:38 PM
Is this ever appropriate or do I have to make a section IV.
November 7, 2025 at 8:40 PM
Is this ever appropriate or do I have to make a section IV.
always the problem. draft is nearly finished at 17000 words. then I edit and now its 21,000 words. want to shave but can't figure out what's best given what I need to cover. I think i will save it for another, more general paper--perhaps an online essay.
November 7, 2025 at 2:55 PM
always the problem. draft is nearly finished at 17000 words. then I edit and now its 21,000 words. want to shave but can't figure out what's best given what I need to cover. I think i will save it for another, more general paper--perhaps an online essay.
@saragerke.bsky.social and I have a new article out in JAMA J. of Ethics
journalofethics.ama-assn.org/article/how-...
journalofethics.ama-assn.org/article/how-...
November 3, 2025 at 6:09 PM
@saragerke.bsky.social and I have a new article out in JAMA J. of Ethics
journalofethics.ama-assn.org/article/how-...
journalofethics.ama-assn.org/article/how-...
Reposting my paper because it was not distributed in many SSRN e-journals--maybe it's a weird fit.
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
November 3, 2025 at 12:48 PM
Reposting my paper because it was not distributed in many SSRN e-journals--maybe it's a weird fit.
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
Always a sobering reminder
November 2, 2025 at 10:56 PM
Always a sobering reminder
found this guy on my walk
October 30, 2025 at 8:10 PM
found this guy on my walk
used to read typos and think, man that’s sloppy for a news organization. Now I think I’m glad I’m reading something written by a person.
October 20, 2025 at 4:01 PM
used to read typos and think, man that’s sloppy for a news organization. Now I think I’m glad I’m reading something written by a person.
our students are incredible, exhibit 231. my former students welcomed me back with a gift from the museum of tort law!
October 17, 2025 at 11:34 AM
our students are incredible, exhibit 231. my former students welcomed me back with a gift from the museum of tort law!
in april, Vanda Pharm sued the FDA over its new guidance on off-label promotion. this underscores the need for a better system, like the one I proposed several years ago--at the very least a better disclosure document. compare industry to my approach (mine is one page but LR margins too wide)
October 7, 2025 at 10:03 PM
in april, Vanda Pharm sued the FDA over its new guidance on off-label promotion. this underscores the need for a better system, like the one I proposed several years ago--at the very least a better disclosure document. compare industry to my approach (mine is one page but LR margins too wide)
Another beautiful day in one of the greatest cities in the world
September 28, 2025 at 11:47 AM
Another beautiful day in one of the greatest cities in the world
Just posted my paper, Off-Label Inducement, to SSRN. It argues for a new (old) tort to hold drug and device manufacturers liable for inducing clinicians to make unsafe off-label uses.
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
September 26, 2025 at 8:52 PM
Just posted my paper, Off-Label Inducement, to SSRN. It argues for a new (old) tort to hold drug and device manufacturers liable for inducing clinicians to make unsafe off-label uses.
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
Always a pleasure to return home to Chicago for the Law & Stem Junior Faculty Forum at Northwestern University Pritzker School of Law. Thanks to David Schwartz, Christopher Yoo, & Mark Lemley, as well as Northwestern, University of Pennsylvania Carey Law School, and Stanford Law School.
September 26, 2025 at 2:30 PM
Always a pleasure to return home to Chicago for the Law & Stem Junior Faculty Forum at Northwestern University Pritzker School of Law. Thanks to David Schwartz, Christopher Yoo, & Mark Lemley, as well as Northwestern, University of Pennsylvania Carey Law School, and Stanford Law School.
Good news nerds, westlaw has finally fixed its copy feature for
September 22, 2025 at 2:00 PM
Good news nerds, westlaw has finally fixed its copy feature for
this apparently is from parfit's widow. one of the first things i did as an undergraduate was read works on friendship and love. i still think about them. this is a stark read
September 19, 2025 at 5:11 PM
this apparently is from parfit's widow. one of the first things i did as an undergraduate was read works on friendship and love. i still think about them. this is a stark read